TargetCytochrome P450 2C19(Homo sapiens (Human))
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Affinity DataIC50: 2.70E+4nMT: 2°CAssay Description:Using a procedure similar to that described in Biological Test Example 6, the inhibition of cytochrome P450 2C19-isoenzyme catalysed N-demethylation ...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)